Lateral Epicondylitis Treatment Market Report 2026

Lateral Epicondylitis Treatment Market Overview

• Lateral Epicondylitis Treatment market size has reached to $2.34 billion in 2025 • Expected to grow to $2.98 billion in 2030 at a compound annual growth rate (CAGR) of 4.9% • Growth Driver: Rise In Sports And Physical Activities Fueling The Growth Of The Market Due To Increasing Health Awareness • Market Trend: Advanced Plasma Therapies Transform Non-Surgical Orthopedic Treatment And Recovery • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lateral Epicondylitis Treatment Market?

Lateral epicondylitis treatment refers to a range of clinical interventions aimed at reducing pain, decreasing inflammation, and promoting recovery in individuals affected by lateral epicondylitis, a condition caused by overuse or strain of the forearm tendons. It is used to restore normal arm function, enhance mobility and strength, and support a return to daily or occupational activities without symptom recurrence. The main treatment types of lateral epicondylitis treatment are non-surgical treatment and surgical treatment. Non-surgical treatment for lateral epicondylitis refers to conservative therapeutic approaches, such as physical therapy, bracing, medications, and regenerative techniques like platelet-rich plasma (PRP), aimed at relieving pain, reducing inflammation, and restoring function without the need for operative intervention. It is used for various age groups including pediatric, adult, and geriatric, and is used in applications such as athletes and others. It is used by various in various end uses such as hospitals, ambulatory surgical centers, orthopedic clinics, homecare settings, and others.

What Is The Lateral Epicondylitis Treatment Market Growth Forecast?

The lateral epicondylitis treatment market size is expected to see steady growth in the next few years. It will grow to $2.98 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to minimally invasive treatment adoption, aging workforce population, digital physiotherapy platforms, demand for faster recovery solutions, outpatient surgical advancements. Major trends in the forecast period include growing preference for non-surgical interventions, increased adoption of physical therapy protocols, rising use of image-guided injections, expansion of outpatient orthopedic care, integration of rehabilitation and pain management.

Global Lateral Epicondylitis Treatment Market Segmentation

1) By Treatment Type: Non-Surgical Treatment, Surgical Treatment 2) By Age Group: Pediatric, Adult, Geriatric 3) By Application: Athlete, Other Applications 4) By End Use: Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Homecare Settings, Other End Uses Subsegments: 1) By Non-Surgical Treatment: Physical Therapy, Pharmacological Therapy, Orthotic Devices, Injections 2) By Surgical Treatment: Open Surgery, Arthroscopic Surgery

What Is The Driver Of The Lateral Epicondylitis Treatment Market?

The growth in sports and physical activities is expected to drive the growth in the lateral epicondylitis treatment market going forward. Sports and physical activities refer to structured or recreational bodily movements undertaken to improve physical fitness, maintain health, or engage in competitive or leisure pursuits. Sports and physical activities are rising due to increased health awareness, as more people prioritize fitness to prevent diseases and improve mental and physical well-being. Lateral epicondylitis treatment is beneficial for sports and physical activities as it helps restore pain-free arm function, allowing individuals to perform movements like gripping and swinging without discomfort or limitation. For instance, in February 2024, according to the Sports and Fitness Industry Association (SFIA), a US-based trade association, 78.8% of Americans, or 242 million people, participated in at least one physical activity in 2023, a 2.2% rise from 2022. Therefore, the growth in sports and physical activities is driving the growth of the lateral epicondylitis treatment industry.

Key Players In The Global Lateral Epicondylitis Treatment Market

Major companies operating in the lateral epicondylitis treatment market are Merck & Co. Inc., 3M Company, Mayo Foundation for Medical Education and Research (MFMER), Cleveland Clinic, Chugai Pharmaceutical, Johns Hopkins Medicine, MedStar Health, Cipla Inc., Enovis Corporation, OttoBock HealthCare, Ossur Corporate, Max Healthcare, Seikagaku Corporation, Texas Orthopedic Specialists, Johari Digital, Mediheal Group of Hospitals, Scandinavian Physiotherapy Center, Veritas Health LLC, Folsom Orthopaedics & Sports Medicine, ReLiva Physiotherapy & Rehab, Molecular Pharmacology Limited

Global Lateral Epicondylitis Treatment Market Trends and Insights

Major companies operating in the lateral epicondylitis treatment market are focusing on developing innovative solutions, such as plasma therapies, to expand treatment options and provide advanced, non-surgical solutions to patients with orthopedic conditions. Plasma therapies involve using components of blood plasma, particularly antibodies or growth factors, to treat various medical conditions and support the body's healing processes. For instance, in December 2023, Tree Top Hospital (TTH), a Maldives-based state-of-the-art hospital, launched platelet-rich plasma (PRP) treatments as part of its advanced orthopedic care services. This innovative therapy leverages the body's natural healing properties to address select musculoskeletal conditions such as lateral epicondylitis (tennis elbow), early-stage knee arthritis, and sports-related tendon injuries. By introducing PRP therapy, TTH aims to enhance patient recovery through minimally invasive, evidence-backed regenerative solutions that reduce dependency on surgical interventions.

What Are Latest Mergers And Acquisitions In The Lateral Epicondylitis Treatment Market?

In March 2023, TendoNova, a US-based company offering treatment for lateral epicondylitis, partnered with AcCELLerated Biologics LLC to enhance market reach and clinical capabilities through strategic alignment between device innovation and biologic solutions. The purpose of this collaboration is to integrate micro-invasive tendon treatment technologies with biologic therapies to expand physician access and improve patient outcomes in the treatment of chronic tendon disorders. AcCELLerated Biologics LLC is a US-based provider of biologic products for lateral epicondylitis treatment.

Regional Insights

North America was the largest region in the lateral epicondylitis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Lateral Epicondylitis Treatment Market?

The lateral epicondylitis treatment market consists of revenues earned by entities by providing services such as outpatient musculoskeletal physiotherapy sessions, telehealth consultations for elbow pain, occupational therapy programs, post-surgical recovery and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The lateral epicondylitis treatment market also includes sales of platelet-rich plasma (PRP) kits, extracorporeal shock wave therapy (ESWT) devices, ultrasound therapy equipment, elbow support braces with biofeedback sensors, and topical anti-inflammatory gels. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Lateral Epicondylitis Treatment Market Report 2026?

The lateral epicondylitis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lateral epicondylitis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.